tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MOLN Stock Latest News

Life Science Cares Launches in Switzerland
Press ReleasesLife Science Cares Launches in Switzerland
9d ago
MOLN
Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting
PremiumPress Releases
Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting
11d ago
MOLN
Molecular Partners Sets Date for 2024 AGM
PremiumCompany Announcements
Molecular Partners Sets Date for 2024 AGM
1M ago
6K
MOLN
Molecular Partners Publishes Invitation to Annual General Meeting 2024
PremiumPress Releases
Molecular Partners Publishes Invitation to Annual General Meeting 2024
1M ago
MOLN
Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023
PremiumPress Releases
Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023
2M ago
MOLN
Molecular Partners Announces Dismissal of Class Action Lawsuit
PremiumPress ReleasesMolecular Partners Announces Dismissal of Class Action Lawsuit
2M ago
MOLN
Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations
PremiumPress Releases
Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations
2M ago
MOLN
Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference
PremiumPress Releases
Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference
4M ago
MOLN
Molecular Partners, Orano Med enter pact to develop Radio-DARPin therapeutics
PremiumThe Fly
Molecular Partners, Orano Med enter pact to develop Radio-DARPin therapeutics
4M ago
MOLN
Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies
PremiumPress Releases
Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies
4M ago
MOLN
Molecular Partners to Present at 42nd Annual J.P. Morgan Healthcare Conference and Swiss Investor Conferences
PremiumPress Releases
Molecular Partners to Present at 42nd Annual J.P. Morgan Healthcare Conference and Swiss Investor Conferences
5M ago
MOLN
Molecular presents data from dosing cohorts of Phase 1/2a trial of MP0533
PremiumThe Fly
Molecular presents data from dosing cohorts of Phase 1/2a trial of MP0533
5M ago
MOLN
Molecular Partners Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at ASH Annual Meeting
PremiumPress ReleasesMolecular Partners Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at ASH Annual Meeting
5M ago
MOLN
Molecular Partners price target lowered by CHF 2 at JPMorgan
PremiumThe Fly
Molecular Partners price target lowered by CHF 2 at JPMorgan
5M ago
MOLN
Molecular Partners price target lowered by $2.10 at JPMorgan, here’s why
PremiumThe Fly
Molecular Partners price target lowered by $2.10 at JPMorgan, here’s why
5M ago
MOLN
Molecular Partners to Present on DARPin Oncology Innovations at Protein & Antibody Engineering Summit Europe (PEGS)
PremiumPress Releases
Molecular Partners to Present on DARPin Oncology Innovations at Protein & Antibody Engineering Summit Europe (PEGS)
6M ago
MOLN
Molecular Partners present updated data from Phase 1 trial of MP0317
PremiumThe Fly
Molecular Partners present updated data from Phase 1 trial of MP0317
6M ago
MOLN
Molecular Partners Presents Updated Positive Data from Ongoing Phase 1 Trial of MP0317 (FAP X CD40) Monotherapy in Patients with Advanced Solid Tumors at the 2023 SITC Annual Meeting
PremiumPress Releases
Molecular Partners Presents Updated Positive Data from Ongoing Phase 1 Trial of MP0317 (FAP X CD40) Monotherapy in Patients with Advanced Solid Tumors at the 2023 SITC Annual Meeting
6M ago
MOLN
Molecular Partners to Present Initial Data from Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at the 65th ASH Annual Meeting and Exposition
PremiumPress Releases
Molecular Partners to Present Initial Data from Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at the 65th ASH Annual Meeting and Exposition
6M ago
MOLN
Molecular Partners to Participate in the TD Cowen 7th Annual Fall Oncology Innovation Summit
PremiumPress ReleasesMolecular Partners to Participate in the TD Cowen 7th Annual Fall Oncology Innovation Summit
6M ago
MOLN
Molecular Partners sees FY23 total expenses of CHF 65-70
PremiumThe Fly
Molecular Partners sees FY23 total expenses of CHF 65-70
6M ago
MOLN
Molecular Partners: Continued validation seen across DARPin portfolio
PremiumThe Fly
Molecular Partners: Continued validation seen across DARPin portfolio
6M ago
MOLN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >